Compositions and methods for regulating peptidyltransferase activity and uses thereof -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
12/15/05 - USPTO Class 514 |  181 views | #20050277607 | Prev - Next | About this Page  514 rss/xml feed  monitor keywords

Compositions and methods for regulating peptidyltransferase activity and uses thereof

Title: Compositions and methods for regulating peptidyltransferase activity and uses thereof


Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), O-glycoside, , Nitrogen Containing Hetero Ring, Polynucleotide (e.g., Rna, Dna, Etc.)

Brief Patent Description - Full Patent Description - Patent Claims

The Patent Description & Claims data below is from USPTO Patent Application 20050277607, Compositions and methods for regulating peptidyltransferase activity and uses thereof.


What is claimed is:

1. A method of identifying a composition which inhibits peptidyl transferase activity by inhibiting the interaction of L41 with ribosomes, comprising the steps of: a) contacting a test composition with a cell, cell extract, or purified cell components containing L41 and ribosomes; b) detecting whether the test composition specifically inhibits the interaction of L41 with the ribosomes; and c) determining whether the test composition inhibits peptidyl transferase activity of the ribosomes.

2. The method of claim 1 wherein the cell or cell extract is from yeast.

3. The method of claim 1 wherein the determining step comprises detecting a decrease in the rate of peptidylpuromycin formation by the ribosomes.

4. A composition identified in accordance with the method of claim 1.

5. A method of inhibiting peptidyl transferase activity in a cell comprising contacting the cell with a composition of claim 4.

6. A method of inhibiting a viral infection in a cell comprising contacting the cell with an effective amount of a composition of claim 4.

7. A method of treating a viral infection in a patient comprising administering to the patient, a therapeutically effective amount of a composition of claim 4.

8. A pharmaceutical composition comprising the composition of claim 4 and a pharmaceutically acceptable carrier.

9. A method of identifying a composition which increases -1PRF efficiencies by inhibiting the interaction of L41 with ribosomes comprising the steps of: a) contacting a test composition with a cell, cell extract, or purified cell components, containing L41 and ribosomes; b) detecting whether the test composition inhibits the interaction of L41 with the ribosomes; and c) determining whether the test composition increases -1PRF efficiencies of the ribosomes.

10. The method of claim 9 wherein the host cell is a yeast cell.

11. The method of claim 9 wherein the determining step comprises an assay of programmed ribosomal frameshifting.

12. A composition identified in accordance with the method of claim 9.

13. A method of increasing -1PRF efficiencies in a cell comprising contacting the cell with a composition of claim 12.

14. A method of inhibiting a viral infection in a cell comprising contacting the cell with an effective amount of a composition of claim 12.

15. A method of treating a viral infection in a patient comprising administering to the patient, a therapeutically effective amount of a composition of claim 12.

16. A pharmaceutical composition comprising the composition of claim 12 and a pharmaceutically acceptable carrier.

17. A composition which inhibits the interaction of L41 with ribosomes and thereby decreases peptidyl transferase activity.

18. The composition of claim 17 comprising a small molecule.

19. A pharmaceutical composition comprising the composition of claim 17 and a pharmaceutically acceptable carrier.

20. A method for treating a viral infection in a patient comprising administering to the patient a therapeutically effective amount of a pharmaceutical composition of claim 19.

Brief Patent Description - Full Patent Description - Patent Claims

Click on the above for other options relating to this Compositions and methods for regulating peptidyltransferase activity and uses thereof patent application.
###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Compositions and methods for regulating peptidyltransferase activity and uses thereof or other areas of interest.
###


Previous Patent Application:
Cationic cardiolipin analoges and its use thereof
Next Patent Application:
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
Industry Class:
Drug, bio-affecting and body treating compositions

###

FreshPatents.com Support
Thank you for viewing the Compositions and methods for regulating peptidyltransferase activity and uses thereof patent info.
IP-related news and info


Results in 0.10674 seconds


Other interesting Feshpatents.com categories:
Computers:  Graphics I/O Processors Dyn. Storage Static Storage Printers 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO